Skip to main content
. 2020 May 27;11:1009. doi: 10.3389/fimmu.2020.01009

Table 1.

Primers used in the Real-time quantitative polymerase chain reaction (qPCR) analyses.

Gene of interest Nucleotide sequence (5-3) bEfficiency (%) Amplicon size (bp) (GenBank Acc. No.) References
Interleukin 1 beta (il1b) F: GTATCCCATCACCCCATCAC
R: TTGAGCAGGTCCTTGTCCTT
99 119 AY617117 (47)
Interleukin 8a (cxcl8, alias il8-a) F: GAAAGCAGACGAATTGGTAGAC
R: GCTGTTGCTCAGAGTTGCAAT
104 99 BT046706 (47)
Cyclooxygenase-2 (cox2) F: ACCTTTGTGCGAAACGCTAT
R: GAGTAGGCCTCCCAGCTCTT
109 113 AY848944 (48)
Cathelicidin b (camp-b) F: AGACTGGCAACACCCTCAAC
R: TTGCCTCTTCTTGTCCGAAT
103 112 AY360357 (49)
Hepcidin a (hamp-a) F: ATGAATCTGCCGATGCATTTC
R: AATGGCTTTAGTGCTGGCAG
96 134 BT125319 (49)
Toll-like receptor 5a (soluble) (stlr5-a) F: ATCGCCCTGCAGATTTTATG
R: GAGCCCTCAGCGAGTTAAAG
96 103 AY628755 (50)
Interferon gamma (ifng) F: CCGTACACCGATTGAGGACT
R: GCGGCATTACTCCATCCTAA
103 133 AJ841811 (48)
Interferon regulatory factor 7b (irf7-b) F: GTCAGTGGTAAAATCAACACGC
R: CACCATCATGAAACGCTTGGT
91 99 FJ517644 (48)
Signal transducer and activator of transcription 1b (stat1-b) F: GTTCAGGATGCAGAGCATGA
R: CCATCCCATTCACCTCTTGT
99 109 BT048927 (48)
Radical S-adenosyl methionine domain containing protein 2b (rsad2-b, alias viperin-b) F: TTCCTGGCATGGATAGGTGT
R: CTTGGAGTTGTCGCTGGTTT
102 113 DY728694 Caballero-Solares et al. (in preparation)
Interferon-induced GTP-binding protein b (mx-b) F: ACGCACCACTCTGGAGAAAT
R: CTTCCATTTCCCGAACTCTG
94 184 BT044881 (48)
Interferon stimulated gene 15a (isg15-a) F: AAAGTGGCCACAACAAAGCAG
R: ATAGGAGCGGGCTCCGTAATC
90 140 BT049918 (48)
aEukaryotic translation initiation factor 3 subunit D (etif3d) F: CTCCTCCTCCTCGTCCTCTT
R: GACCCCAACAAGCAAGTGAT
94 105 GE777139 (48)
aPolyadenylate-binding protein 1 (pabpc1) F: TGACCGTCTCGGGTTTTTAG
R: CCAAGGTGGATGAAGCTGTT
102 108 EG908498 (48)
a

Normalizers.

b

Amplification efficiencies were calculated using a 5-point 1:3 dilution series starting with cDNA representing 10 ng of input total RNA. See methods for details.